CPHI
China Pharma Holdings Inc
NYSE MKT: CPHI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.55
-0.16% today
Updated 2026-04-30
Market cap
$25.50M
P/E ratio
—
P/S ratio
6.15x
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
WallStSmart proprietary scores
35
out of 100
Grade: D
Sell
Investment rating
4.0
Growth
C5.0
Quality
C+2.0
Profitability
F8.3
Valuation
A—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$3.00
+446.45%
12-Month target
—
—
Intrinsic (DCF)
$1.18
Margin of safety
+46.74%
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $146223.00 — positive
+ 46.74% below intrinsic value
Risks
- Thin margins at -76.90%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $8.10M | $7.01M | $4.53M | $4.14M | $4.14M |
| Net income | $-3.97M | $-3.08M | $-4.74M | $-3.19M | $-1.22M |
| EPS | — | — | — | — | $-0.74 |
| Free cash flow | $-811509.00 | $-711203.00 | $-758080.00 | $11010.00 | $146223.00 |
| Profit margin | -49.02% | -43.91% | -104.58% | -76.91% | -76.90% |
Peer comparison
Smart narrative
China Pharma Holdings Inc trades at $0.55. Our Smart Value Score of 35/100 indicates the stock is weak. TTM revenue stands at $4.14M. with profit margins at -76.90%. Our DCF model estimates intrinsic value at $1.18.
Frequently asked questions
What is China Pharma Holdings Inc's stock price?
China Pharma Holdings Inc (CPHI) trades at $0.55.
Is China Pharma Holdings Inc overvalued?
Smart Value Score 35/100 (Grade D, Sell). DCF value $1.18.
What is the price target of China Pharma Holdings Inc (CPHI)?
The analyst target price is $3.00, representing +446.4% upside from the current price of $0.55.
What is the intrinsic value of China Pharma Holdings Inc (CPHI)?
Based on our DCF model, intrinsic value is $1.18, a +46.7% margin of safety versus $0.55.
What is China Pharma Holdings Inc's revenue?
TTM revenue is $4.14M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryChina
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio6.15x
ROE-20.90%
Beta1.09
50D MA$0.62
200D MA$1.33
Shares out0.04B
Float0.04B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—